Steady-State Concentration Achievement

Steady-state concentration achievement occurs after multiple drug doses accumulate producing consistent plasma levels. Time-to-steady-state depends on drug half-life. Accumulation factor predicts steady-state from single-dose data. Loading dose strategy accelerates steady-state achievement. Maintenance dosing sustains therapeutic levels.

Therapeutic drug monitoring guides dose adjustments. Clinical response assessment confirms steady-state adequacy. Regulatory submissions justify dosing regimens. Post-approval monitoring confirms achievement timelines. Emerging population pharmacokinetics personalises timelines.